Hepatic steatosis in women with polycystic ovary syndrome
Abstract Background This multi-center, cross-sectional study intended to explore the prevalence and risk factors of nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) in patients with polycystic ovary syndrome (PCOS). Methods Patients who met th...
Main Authors: | Xinyu Hong, Zaixin Guo, Qi Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-023-01456-6 |
Similar Items
-
Prevalence of hepatic steatosis in women with polycystic ovary syndrome
by: Ritu Karoli, et al.
Published: (2013-01-01) -
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center
by: Daniela Oliveira de Lima Taranto, et al.
Published: (2020-06-01) -
Relationships between nonalcoholic fatty liver disease and polycystic ovary syndrome
by: E.H. Manzhalii, et al.
Published: (2023-12-01) -
Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease
by: Chang-Hai Liu, et al.
Published: (2022-06-01) -
Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
by: Jieun Chung, et al.
Published: (2021-11-01)